Atricure Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 750
Employees
  • Stock Symbol
  • ATRC
Stock Symbol
  • Investments
  • 5
  • Share Price
  • $68.00
  • (As of Friday Closing)

Atricure General Information

Description

AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Stock Exchange
NAS
Primary Office
  • 7555 Innovation Way
  • Mason, OH 45040
  • United States
+1 (513) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atricure Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$68.00 $67.59 $34.04 - $68.30 $3.1B 45.6M 381K -$1.14

Atricure Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,347,924 2,347,924 1,282,459 1,191,146
Revenue 206,531 206,531 230,807 201,630
EBITDA (34,709) (34,709) (23,916) (8,556)
Net Income (48,155) (48,155) (35,194) (21,137)
Total Assets 714,539 714,539 557,880 356,759
Total Debt 74,001 74,001 76,422 52,460
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Atricure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
AtriCure Inc an atrial fibrillation solutions company that provides products, professional education, and support for cl
Surgical Devices
Mason, OH
750 As of 2020
0000
0000 0000-00-00
00000000 0000

0000000

consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nu
00000000 0000000
Princeton, NJ
0000 As of 0000
00000
000000 - 000 00000

00000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
00000000 0000000
Morrisville, NC
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atricure Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Integra LifeSciences Corporation Princeton, NJ 0000 00000 000000 - 000 00000
000000000000 Formerly VC-backed Morrisville, NC 000 00000 00000000000 00000
00000 0000000 Corporation Toronto, Canada 00 00000 000000000 00000
0000000 Private Equity-Backed Yokneam, Israel 0000 00000 000000000000 00000
00000000000 Venture Capital-Backed Marlborough, MA 00 00000 000000 - 000 00000
You’re viewing 5 of 21 competitors. Get the full list »

Atricure Executive Team (10)

Name Title Board Seat Contact Info
Michael Carrel Chief Executive Officer & Board Member
Angela Wirick Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Douglas Seith Chief Operating Officer, Operations
Justin Noznesky Senior Vice President, Marketing and Business Development
Sam Privitera JD Chief Technical Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Atricure Board Members (15)

Name Representing Role Since
Daniel Florin Self Board Member 000 0000
Karen Prange Atricure Board Member 000 0000
Kristine Johnson Self Board Member 000 0000
Mark Collar Self Board Member 000 0000
Mark Lanning Atricure Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Atricure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atricure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Atricure‘s full profile, request access.

Request a free trial

Atricure Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 13-Aug-2019 000000000000000000 00000 Surgical Devices
00000000 13-Oct-2015 000000000000000000 00000 Surgical Devices 0000000 000000
000000 02-Jan-2014 000000000000000000 000.00 Medical Supplies
00000000000000 (00 07-Sep-2007 000000000 00000 00 00.000 Buildings and Property 00000 00000000
Enable Medical 10-Aug-2005 Merger/Acquisition 000 Surgical Devices
To view Atricure’s complete investments and acquisitions history, request access »